Loading...

Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center Experience

PURPOSE: Dramatic advances in our understanding of the molecular pathophysiology of cancer, along with a rapidly expanding portfolio of molecular targeted drugs, have led to a paradigm shift toward personalized, biomarker-driven cancer treatment. Here, we report the 2-year experience of the Comprehe...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JCO Precis Oncol
Main Authors: Hoefflin, Rouven, Geißler, Anna-Lena, Fritsch, Ralph, Claus, Rainer, Wehrle, Julius, Metzger, Patrick, Reiser, Meike, Mehmed, Leman, Fauth, Lisa, Heiland, Dieter Henrik, Erbes, Thalia, Stock, Friedrich, Csanadi, Agnes, Miething, Cornelius, Weddeling, Britta, Meiss, Frank, von Bubnoff, Dagmar, Dierks, Christine, Ge, Isabell, Brass, Volker, Heeg, Steffen, Schäfer, Henning, Boeker, Martin, Rawluk, Justyna, Botzenhart, Elke Maria, Kayser, Gian, Hettmer, Simone, Busch, Hauke, Peters, Christoph, Werner, Martin, Duyster, Justus, Brummer, Tilman, Boerries, Melanie, Lassmann, Silke, von Bubnoff, Nikolas
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446498/
https://ncbi.nlm.nih.gov/pubmed/32913998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00105
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!